RadNet Inc
NASDAQ:RDNT

Watchlist Manager
RadNet Inc Logo
RadNet Inc
NASDAQ:RDNT
Watchlist
Price: 73.24 USD -0.16% Market Closed
Market Cap: 5.4B USD
Have any thoughts about
RadNet Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one RDNT stock under the Base Case scenario is 52.54 USD. Compared to the current market price of 73.24 USD, RadNet Inc is Overvalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RDNT Relative Value
Base Case
52.54 USD
Overvaluation 28%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.1
P/S
P/S
Price to Sales
3.1
vs History
0
vs Industry
41
Median 3Y
1.2
Median 5Y
1
Industry
2.3
Forward
2.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
1
Median 3Y
65.2
Median 5Y
65.2
Industry
23.1
Forward
109.3
More Details
19.4
P/OCF
P/OCF
Price to OCF
19.4
vs History
0
vs Industry
18
Median 3Y
10.4
Median 5Y
9.4
Industry
14.2
More Details
29.1
P/FCFE
P/FCFE
Price to FCFE
29.1
vs History
9
vs Industry
7
Median 3Y
-24
Median 5Y
11.5
Industry
20.1
More Details
6.1
P/B
P/B
Price to Book Value
6.1
vs History
19
vs Industry
16
Median 3Y
4.1
Median 5Y
5.2
Industry
2.2
More Details
3.2
EV/S
EV/S
Enterprise Value to Sales
3.2
vs History
0
vs Industry
38
Median 3Y
1.7
Median 5Y
1.5
Industry
2.4
Forward
3
More Details
13.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.7
vs History
0
vs Industry
15
Median 3Y
7.4
Median 5Y
7
Industry
5
More Details
22.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22.9
vs History
0
vs Industry
16
Median 3Y
12.5
Median 5Y
12.8
Industry
12.7
Forward
19.8
More Details
50.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
50.2
vs History
14
vs Industry
7
Median 3Y
35.9
Median 5Y
35.9
Industry
17.1
Forward
43.6
More Details
20.3
EV/OCF
EV/OCF
Enterprise Value to OCF
20.3
vs History
1
vs Industry
17
Median 3Y
14.1
Median 5Y
13.4
Industry
14
More Details
60.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
60.1
vs History
30
vs Industry
2
Median 3Y
66.8
Median 5Y
54.4
Industry
18
More Details
2.6
EV/IC
EV/IC
Enterprise Value to IC
2.6
vs History
0
vs Industry
33
Median 3Y
1.3
Median 5Y
1.2
Industry
1.9
More Details

Multiples Across Competitors

RDNT Competitors Multiples
RadNet Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
RadNet Inc
NASDAQ:RDNT
5.4B USD 3.1 -1 228 22.9 50.2
US
Cigna Corp
NYSE:CI
78.4B USD 0.3 25.8 8.1 10.4
US
Cigna Group
XMUN:CGN
75.1B EUR 0.3 25.7 8 10.4
US
CVS Health Corp
NYSE:CVS
57.1B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.8B EUR 1.3 48.6 11.2 25.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.4 13.2 20.4
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.8B EUR 0.7 24.1 7 16.2
US
DaVita Inc
NYSE:DVA
12.8B USD 1 15.5 8 11.1
P/E Multiple
Earnings Growth P/E to Growth
US
RadNet Inc
NASDAQ:RDNT
Average P/E: 27
Negative Multiple: -1 228
2 257%
N/A
US
Cigna Corp
NYSE:CI
25.8
96%
0.3
US
C
Cigna Group
XMUN:CGN
25.7
96%
0.3
US
CVS Health Corp
NYSE:CVS
11.3
8%
1.4
DE
Fresenius Medical Care AG
XMUN:FME
48.6
127%
0.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.2 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.4
263%
0.2
US
Quest Diagnostics Inc
NYSE:DGX
20.4
41%
0.5
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
4 308%
N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.1
127%
0.2
US
DaVita Inc
NYSE:DVA
15.5
61%
0.3

See Also

Summary
RDNT intrinsic value, competitors valuation, and company profile.
DCF Valuation
RDNT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RDNT stock valuation using valuation multiples.
Wall Street Estimates
RDNT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RDNT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.